Manufacturing road map for tissue engineering and regenerative medicine technologies

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Biotechnology Manufacturing

Background:

• The Regenerative Medicine Foundation Annual Conference (2014) aimed to advance the clinical translation of tissue engineering and regenerative medicine (TERM) technologies.
• Key areas discussed included regulatory pathways, industry partnerships, resource coordination, standards development, and government support.

Purpose of the Study:

• To identify and address roadblocks in the clinical translation and manufacturing scale-up of regenerative medicine therapies.
• To outline a roadmap for developing essential TERM manufacturing infrastructure, resources, standards, and workforce capabilities.

Main Methods:

• Focused manufacturing sessions with experts from industry, government, and academia.
• Industry survey to further identify challenges in translation and scale-up.
• Analysis of lessons learned from conference sessions and survey results.

Main Results:

• Advanced manufacturing improvements offer solutions to identified roadblocks in regenerative medicine.
• Specific challenges in product development, process scale-up, and infrastructure needs were detailed.
• Early survey results provided further insights into translation and scale-up hurdles.

Conclusions:

• Developing a comprehensive roadmap is crucial for advancing regenerative medicine manufacturing.
• Addressing infrastructure, resources, standards, education, and workforce development is essential to realize the full potential of TERM therapies.